title: A phase 2 study of bortezomib, cyclophosphamide, pegylated liposomal doxorubicin and dexamethasone for newly diagnosed multiple myeloma.
authors.affiliation: Divisions of Hematology and Medical Oncology, University of Washington, Seattle, WA, USA.|Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.|Seattle Cancer Care Alliance, Seattle, WA, USA.
authors.forename: P S
authors.initials: PS
authors.lastname: Becker
authors.affiliation: Divisions of Hematology and Medical Oncology, University of Washington, Seattle, WA, USA.|Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
authors.forename: T A
authors.initials: TA
authors.lastname: Gooley
authors.affiliation: Divisions of Hematology and Medical Oncology, University of Washington, Seattle, WA, USA.|Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.|Seattle Cancer Care Alliance, Seattle, WA, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Green
authors.affiliation: Divisions of Hematology and Medical Oncology, University of Washington, Seattle, WA, USA.
authors.forename: N
authors.initials: N
authors.lastname: Burwick
authors.affiliation: Skagit Valley Hospital Regional Cancer Care Center, Mount Vernon, WA, USA.
authors.forename: T Y
authors.initials: TY
authors.lastname: Kim
authors.affiliation: Skagit Valley Hospital Regional Cancer Care Center, Mount Vernon, WA, USA.
authors.forename: K
authors.initials: K
authors.lastname: Kojouri
authors.affiliation: Providence Regional Cancer Partnership, Everett, WA, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Inoue
authors.affiliation: Seattle Cancer Care Alliance, Seattle, WA, USA.|SCCA at Evergreen Health, Kirkland, WA, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Moore
authors.affiliation: Hematology Oncology Associates, Medford, OR, USA.
authors.forename: E
authors.initials: E
authors.lastname: Nelli
authors.affiliation: MultiCare Health System, Tacoma, WA, USA.
authors.forename: T
authors.initials: T
authors.lastname: Dennie
authors.affiliation: Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.|Swedish Cancer Institute, Seattle, WA, USA.
authors.forename: W I
authors.initials: WI
authors.lastname: Bensinger
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069286:Bortezomib / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003907:Dexamethasone / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D020360:Neoadjuvant Therapy; D011092:Polyethylene Glycols / Q000008:administration & dosage; D012008:Recurrence; D033581:Stem Cell Transplantation; D016019:Survival Analysis; D019172:Transplantation Conditioning / Q000379:methods; D014182:Transplantation, Autologous; D055815:Young Adult
chemical_list: C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D000069286:Bortezomib; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide